4.6 Article

Epigenetic foundations of pluripotent stem cells that recapitulate in vivo pluripotency

Journal

LABORATORY INVESTIGATION
Volume 97, Issue 10, Pages 1133-1141

Publisher

SPRINGERNATURE
DOI: 10.1038/labinvest.2017.87

Keywords

-

Funding

  1. P-CREATE, Japan Agency for Medical Research and Development (AMED)
  2. SICORP, AMED
  3. Research Center Network for Realization of Regenerative Medicine, AMED
  4. JSPS KAKENHI [15H04721, 15J05792]
  5. Princess Takamatsu Cancer Research Fund
  6. Takeda Science Foundation
  7. Naito Foundation
  8. Grants-in-Aid for Scientific Research [15J05792, 15H04721] Funding Source: KAKEN

Ask authors/readers for more resources

In mammalian development, dynamic epigenetic reprogramming occurs in pre-implantation embryos and primordial germ cells and plays a critical role in conferring pluripotency on embryonic cells. Pluripotent stem cells, such as embryonic stem cells and induced pluripotent stem cells, have been derived and maintained in vitro under culture conditions that include stimulators and inhibitors of extrinsic signaling. Recent advances in stem cell cultivation have opened the possibility of capturing naive pluripotency, which is reminiscent of the pluripotency of inner cell mass cells, in vitro. However, emerging evidence has revealed complexity of epigenetic regulation in pluripotent stem cells in vitro that reflects the developmental stage, gender, and species. In this review, we describe the developmental potential and epigenetic regulation of pluripotent stem cells in rodents and humans in vitro and discuss unsolved issues in developing strategies to capture in vivo pluripotency in vitro.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available